You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Dow
Harvard Business School
McKinsey
Merck

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Betamethasone valerate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for betamethasone valerate and what is the scope of patent protection?

Betamethasone valerate is the generic ingredient in eight branded drugs marketed by Perrigo Uk Finco, Riconpharma Llc, Taro, Mylan, Cosette, Roaco, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Savage Labs, Schering, Actavis Mid Atlantic, Anima, and Teva Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone valerate. Fourteen suppliers are listed for this compound.

Drug Prices for betamethasone valerate

See drug prices for betamethasone valerate

Recent Clinical Trials for betamethasone valerate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sheffield Teaching Hospitals NHS Foundation TrustPhase 2
University of SheffieldPhase 2
Association pour la Recherche Clinique et ImmunologiqueN/A

See all betamethasone valerate clinical trials

Pharmacology for betamethasone valerate
Medical Subject Heading (MeSH) Categories for betamethasone valerate
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename Dosage Ingredient NDA Submissiondate
LUXIQ AEROSOL, FOAM;TOPICAL betamethasone valerate 020934 2007-08-10

US Patents and Regulatory Information for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 071883-001 Apr 22, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette BETA-VAL betamethasone valerate LOTION;TOPICAL 070072-001 Jun 27, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Roaco BETADERM betamethasone valerate CREAM;TOPICAL 018839-001 Jun 30, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999   Start Trial   Start Trial
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Medtronic
Harvard Business School
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.